Vitamin A is an important constituent of the epidermis, where it plays a crucial role in epidermal turnover. A deficiency of epidermal vitamin A may be the consequence of nutritional vitamin A deficiency, exposure to sunlight or any UV source, oxidative stress or chronological ageing. As a consequence, any treatment aiming at increasing epidermal vitamin A would exert a protective effect against these deleterious conditions. Retinoids may counteract some deleterious actions of UV radiation by physical and biological mechanisms. Topical natural retinoic acid precursors such as retinaldehyde or retinol are less irritant than acidic retinoids and may prevent epidermal vitamin A deficiency due to nutritional deficiency, exposure to sunlight or any condition leading to free radical production. Retinoids may be combined with other compounds with complementary actions against ageing, nutritional deficiency and cancer, such as antioxidants, to potentiate their beneficial effects in the skin.

Keywords:
Vitamin A, Retinoids, Ageing, Skin, UV radiation, Antioxidants, Cancer
1.
Castenmiller JJM, West CE: Bioavailability and bioconversion of carotenoids. Annu Rev Nutr 1998;18:19-38.
2.
Roos TC, Jugert FK, Merk HF, Bickers DR: Retinoid metabolism in the skin. Pharmacol Rev 1998;50:315-333.
3.
Sorg O, Tran C, Carraux P, Grand D, Barraclough C, Arrighi JF, Descombes P, Piguet V, Saurat JH: Metabolism and biological activities of topical 4-oxoretinoids in mouse skin. J Invest Dermatol 2008;128:999-1008.
4.
Sorg O, Kaya G, Kasraee B, Saurat JH: Retinoids; in Draelos ZD (ed): Cosmetic Dermatology: Products & Procedures. Singapore, Wiley-Blackwell, 2010, pp 309-318.
5.
Altucci L, Leibowitz MD, Ogilvie KM, de Lera AR, Gronemeyer H: RAR and RXR modulation in cancer and metabolic disease. Nat Rev Drug Discov 2007;6:793-810.
6.
Chapellier B, Mark M, Messaddeq N, Calleja C, Warot X, Brocard J, Gerard C, Li M, Metzger D, Ghyselinck NB, Chambon P: Physiological and retinoid-induced proliferations of epidermis basal keratinocytes are differently controlled. EMBO J 2002;21:3402-3413.
7.
Fisher GJ, Voorhees JJ: Molecular mechanisms of retinoid actions in skin. FASEB J 1996;10:1002-1013.
8.
Futoryan T, Gilchrest BA: Retinoids and the skin. Nutr Rev 1994;52:299-310.
9.
Saurat JH: How do retinoids work on human epidermis? A breakthrough and its implications. Clin Exp Dermatol 1988;13:350-364.
10.
Vahlquist A: Vitamin A in human skin: I. Detection and identification of retinoids in normal epidermis. J Invest Dermatol 1982;79:89-93.
11.
Saurat JH, Sorg O, Didierjean L: New concepts for delivery of topical retinoid activity to human skin; in Nau H, Blaner WS (eds): Retinoids: The Biochemical and Molecular Basis of Vitamin A and Retinoid Action. Berlin, Springer, 1999, pp 521-538.
12.
Törmä H, Vahlquist A: Vitamin A esterification in human epidermis: a relation to keratinocyte differentiation. J Invest Dermatol 1990;94:132-138.
13.
Vahlquist A, Lee JB, Michaëlsson G, Rollman O: Vitamin A in human skin: II. Concentrations of carotene, retinol and dehydroretinol in various components of normal skin. J Invest Dermatol 1982;79:94-97.
14.
Didierjean L, Carraux P, Grand D, Sass JO, Nau H, Saurat JH: Topical retinaldehyde increases skin content of retinoic acid and exerts biological activity in mouse skin. J Invest Dermatol 1996;107:714-719.
15.
Kang S, Duell EA, Fisher GJ, Datta SC, Wang ZQ, Reddy AP, Tavakkol A, Yi JY, Griffiths CEM, Elder JT, Voorhees JJ: Application of retinol to human skin in vivo induces epidermal hyperplasia and cellular retinoid binding proteins characteristics of retinoic acid but without measurable retinoic acid levels or irritation. J Invest Dermatol 1995;105:549-556.
16.
Sass JO, Didierjean L, Carraux P, Plum C, Nau H, Saurat JH: Metabolism of topical retinaldehyde and retinol by mouse skin in vivo: predominant formation of retinyl esters and identification of 14-hydroxy-4,14-retro-retinol. Exp Dermatol 1996;5:267-271.
17.
Duell EA, Åström A, Griffiths CEM, Chambon P, Voorhees JJ: Human skin levels of retinoic acid and cytochrome P-450-derived 4-hydroxyretinoic acid after topical application of retinoic acid in vivo compared to concentrations required to stimulate retinoic acid receptor-mediated transcription in vitro. J Clin Invest 1992;90:1269-1274.
18.
Duester G: Families of retinoid dehydrogenases regulating vitamin A function: production of visual pigment and retinoic acid. Eur J Biochem 2000;267:4315-4324.
19.
Gao J, Simon M: Identification of a novel keratinocyte retinyl ester hydrolase as a transacylase and lipase. J Invest Dermatol 2005;124:1259-1266.
20.
Haselbeck RJ, Ang HL, Duester G: Class IV alcohol/retinol dehydrogenase localization in epidermal basal layer: potential site of retinoic acid synthesis during skin development. Dev Dyn 1997;208:447-453.
21.
Jurukovski V, Simon M: Epidermal growth factor signaling pathway influences retinoid metabolism by reduction of retinyl ester hydrolase activities in normal and malignant keratinocytes. J Cell Physiol 2000;183:265-272.
22.
Napoli JL: Interactions of retinoid binding proteins and enzymes in retinoid metabolism. Biochim Biophys Acta 1999;1440:139-162.
23.
Popa C, Dicker AJ, Dahler AL, Saunders NA: Cytochrome P450, CYP26AI, is expressed at low levels in human epidermal keratinocytes and is not retinoic acid-inducible. Br J Dermatol 1999;141:460-468.
24.
Taimi M, Helvig C, Wisniewski J, Ramshaw H, White J, Amad M, Korczak B, Petkovich M: A novel human cytochrome P450, CYP26C1, involved in metabolism of 9-cis and all-trans isomers of retinoic acid. J Biol Chem 2004;279:77-85.
25.
Kurlandsky SB, Xiao JH, Duell EA, Voorhees JJ, Fisher GJ: Biological activity of all-trans retinol requires metabolic conversion to all-trans retinoic acid and is mediated through activation of nuclear retinoid receptors in human keratinocytes. J Biol Chem 1994;269:32821-32827.
26.
Kurlandsky SB, Duell EA, Kang S, Voorhees JJ, Fisher GJ: Auto-regulation of retinoic acid biosynthesis through regulation of retinol esterification in human keratinocytes. J Biol Chem 1996;271:15346-15352.
27.
Miller SJ: Nutritional deficiency and the skin. J Am Acad Dermatol 1989;21:1-30.
28.
Johnson KA, Bernard MA, Funderburg K: Vitamin nutrition in older adults. Clin Geriatr Med 2002;18:773-799.
29.
Andersson E, Rosdahl I, Törmä H, Vahlquist A: Ultraviolet irradiation depletes cellular retinol and alters the metabolism of retinoic acid in cultured human keratinocytes and melanocytes. Melanoma Res 1999;9:339-346.
30.
Berne B, Nilsson M, Vahlquist A: UV irradiation and cutaneous vitamin A: an experimental study in rabbit and human skin. J Invest Dermatol 1984;83:401-404.
31.
Mousseron-Canet M: Photochemical transformation of vitamin A. Methods Enzymol 1971;180:591-615.
32.
Sorg O, Tran C, Carraux P, Didierjean L, Saurat JH: Retinol and retinyl ester epidermal pools are not identically sensitive to UVB irradiation and antioxidant protective effect. Dermatology 1999;199:302-307.
33.
Sorg O, Tran C, Didierjean L, Saurat JH: Ultraviolets et vitamine A cutanée: une cible méconnue. Med Hyg (Geneve) 2000;58:545-549.
34.
Ihara H, Hashizume N, Hirase N, Suzue R: Esterification makes retinol more labile to photolysis. J Nutr Sci Vitaminol (Tokyo) 1999;45:353-358.
35.
Torras H: Retinoids in aging. Clin Dermatol 1996;14:207-215.
36.
Favennec L, Cals MJ: The biological effects of retinoids on cell differentiation and proliferation. J Clin Chem Clin Biochem 1988;26:479-489.
37.
Giudice GJ, Fuchs EV: Vitamin A-mediated regulation of keratinocyte differentiation. Methods Enzymol 1990;190:18-29.
38.
Ponec M, Weerheim A, Havekes L, Boonstra J: Effects of retinoids on differentiation, lipid metabolism, epidermal growth factor, and low-density lipoprotein binding in squamous carcinoma cells. Exp Cell Res 1987;171:426-435.
39.
West KP Jr: Vitamin A deficiency disorders in children and women. Food Nutr Bull 2003;24(4 suppl):S78-S90.
40.
Goodman DS: Vitamin A and retinoids in health and disease. N Engl J Med 1984;310:1023-1031.
41.
Maronn M, Allen DM, Esterly NB: Phrynoderma: a manifestation of vitamin A deficiency? … The rest of the story. Pediatr Dermatol 2005;22:60-63.
42.
Levine N: Role of retinoids in skin cancer treatment and prevention. J Am Acad Dermatol 1998;39:S62-S66.
43.
Marks R: Retinoids in Cutaneous Malignancy. Oxford, Blackwell Scientific, 1991.
44.
Moon TE, Levine N, Cartmel B, Bangert JL: Retinoids in prevention of skin cancer. Cancer Lett 1997;114:203-205.
45.
Einspahr JG, Bowden GT, Alberts DS: Skin cancer chemoprevention: strategies to save our skin. Recent Results Cancer Res 2003;163:151-164; discussion 264-266.
46.
Fields AL, Soprano DR, Soprano KJ: Retinoids in biological control and cancer. J Cell Biochem 2007;102:886-898.
47.
Agarwal R, Mukhtar H: Chemoprevention of photocarcinogenesis. Photochem Photobiol 1996;63:440-444.
48.
Camacho LH: Clinical applications of retinoids in cancer medicine. J Biol Regul Homeost Agents 2003;17:98-114.
49.
Carr DR, Trevino JJ, Donnelly HB: Retinoids for chemoprophylaxis of nonmelanoma skin cancer. Dermatol Surg 2011;37:129-145.
50.
DiGiovanna JJ: Retinoid chemoprevention in patients at high risk for skin cancer. Med Pediatr Oncol 2001;36:564-567.
51.
Saurat JH: Skin, sun, and vitamin A: from aging to cancer. J Dermatol 2001;28:595-598.
52.
Anderson RR, Parrish JA: The optics of human skin. J Invest Dermatol 1981;77:13-19.
53.
Young AR: Chromophores in human skin. Phys Med Biol 1997;42:789-802.
54.
Mohammad T, Morrison H, HogenEsch H: Urocanic acid photochemistry and photobiology. Photochem Photobiol 1999;69:115-135.
55.
Gibbs NK, Norval M: Urocanic acid in the skin: a mixed blessing? J Invest Dermatol 2011;131:14-17.
56.
Garssen J, Vandebriel RJ, van Loveren H: Molecular aspects of UVB-induced immunosuppression. Arch Toxicol Suppl 1997;19:97-109.
57.
Wille JJ, Kydonieus AF, Murphy GF: cis-urocanic acid induces mast cell degranulation and release of preformed TNF-alpha: a possible mechanism linking UVB and cis-urocanic acid to immunosuppression of contact hypersensitivity. Skin Pharmacol Appl Skin Physiol 1999;12:18-27.
58.
Douki T, Reynaud-Angelin A, Cadet J, Sage E: Bipyrimidine photoproducts rather than oxidative lesions are the main type of DNA damage involved in the genotoxic effect of solar UVA radiation. Biochemistry 2003;42:9221-9226.
59.
Schuch AP, Garcia CC, Makita K, Menck CF: DNA damage as a biological sensor for environmental sunlight. Photochem Photobiol Sci 2013;12:1259-1272.
60.
Merwald H, Klosner G, Kokesch C, Der-Petrossian M, Hönigsmann H, Trautinger F: UVA-induced oxidative damage and cytotoxicity depend on the mode of exposure. J Photochem Photobiol B 2005;79:197-207.
61.
Sorg O, Tran C, Carraux P, Didierjean L, Falson F, Saurat JH: Oxidative stress-independent depletion of epidermal vitamin A by UVA. J Invest Dermatol 2002;118:513-518.
62.
Hoerter JD, Ward CS, Bale KD, Gizachew AN, Graham R, Reynolds J, Ward ME, Choi C, Kagabo JL, Sauer M, Kuipers T, Hotchkiss T, Banner N, Chellson RA, Ohaeri T, Gant L, Vanderhill L: Effect of UVA fluence rate on indicators of oxidative stress in human dermal fibroblasts. Int J Biol Sci 2008;4:63-70.
63.
Lehmann B, Sauter W, Knuschke P, Dressler S, Meurer M: Demonstration of UVB-induced synthesis of 1 alpha,25-dihydroxyvitamin D3 (calcitriol) in human skin by microdialysis. Arch Dermatol Res 2003;295:24-28.
64.
Rajakumar K, Greenspan SL, Thomas SB, Holick MF: SOLAR ultraviolet radiation and vitamin D: a historical perspective. Am J Public Health 2007;97:1746-1754.
65.
Sorg O, Antille C, Saurat JH: Retinoids, other topical vitamins, and antioxidants; in Rigel DS, Weiss RS, Lim HW, Dover JS (eds): Photoaging. New York, Marcel Dekker, 2004, pp 89-115.
66.
Tafrova JI, Pinkas-Sarafova A, Stolarzewicz E, Parker KA, Simon M: UVA/B exposure promotes the biosynthesis of dehydroretinol in cultured human keratinocytes. Mol Cell Biochem 2012;364:351-361.
67.
Wang Z, Boudjelal M, Kang S, Voorhees JJ, Fisher GJ: Ultraviolet irradiation of human skin causes functional vitamin A deficiency, preventable by all-trans retinoic acid pre-treatment. Nat Med 1999;5:418-422.
68.
Gilchrest B: Anti-sunshine vitamin A. Nat Med 1999;5:376-377.
69.
Cherng SH, Xia Q, Blankenship LR, Freeman JP, Wamer WG, Howard PC, Fu PP: Photodecomposition of retinyl palmitate in ethanol by UVA light-formation of photodecomposition products, reactive oxygen species, and lipid peroxides. Chem Res Toxicol 2005;18:129-138.
70.
Fu PP, Xia Q, Yin JJ, Cherng SH, Yan J, Mei N, Chen T, Boudreau MD, Wamer WG: Photodecomposition of vitamin A and photobiological implications for the skin. Photochem Photobiol 2007;83:409-424.
71.
Young AM, Gregoriadis G: Photolysis of retinol in liposomes and its protection with tocopherol and oxybenzone. Photochem Photobiol 1996;63:344-352.
72.
Mei N, Xia Q, Chen L, Moore MM, Fu PP, Chen T: Photomutagenicity of retinyl palmitate by ultraviolet A irradiation in mouse lymphoma cells. Toxicol Sci 2005;88:142-149.
73.
O'Connell MJ, Chua R, Hoyos B, Buck J, Chen Y, Derguini F, Hammerling U: Retro-retinoids in regulated cell growth and death. J Exp Med 1996;184:549-555.
74.
Sorg O: Oxidative stress: a theoretical model or a biological reality? C R Biol 2004;327:649-662.
75.
Sorg O, Kaya G: Oxidative stress in human pathology. Adv Gene Mol Cell Ther 2007;1:56-67.
76.
Halliwell B, Gutteridge JMC: Free Radicals in Biology and Medicine. Oxford, Oxford University Press, 2007.
77.
Fuchs J, Zollner TM, Kaufmann R, Podda M: Redox-modulated pathways in inflammatory skin diseases. Free Radic Biol Med 2001;30:337-353.
78.
Trouba KJ, Hamadeh HK, Amin RP, Germolec DR: Oxidative stress and its role in skin disease. Antioxid Redox Signal 2002;4:665-673.
79.
Schulze-Osthoff K, Bauer MK, Vogt M, Wesselborg S: Oxidative stress and signal transduction. Int J Vitam Nutr Res 1997;67:336-342.
80.
Park SK, Dahmer MK, Quasney MW: MAPK and JAK-STAT signaling pathways are involved in the oxidative stress-induced decrease in expression of surfactant protein genes. Cell Physiol Biochem 2012;30:334-346.
81.
Yu H, Liu Z, Zhou H, Dai W, Chen S, Shu Y, Feng J: JAK-STAT pathway modulates the roles of iNOS and COX-2 in the cytoprotection of early phase of hydrogen peroxide preconditioning against apoptosis induced by oxidative stress. Neurosci Lett 2012;529:166-171.
82.
Korkina L, Pastore S: The role of redox regulation in the normal physiology and inflammatory diseases of skin. Front Biosci (Elite Ed) 2009;1:123-141.
83.
Zhou Q, Mrowietz U, Rostami-Yazdi M: Oxidative stress in the pathogenesis of psoriasis. Free Radic Biol Med 2009;47:891-905.
84.
Okayama Y: Oxidative stress in allergic and inflammatory skin diseases. Curr Drug Targets Inflamm Allergy 2005;4:517-519.
85.
Dell'anna ML, Picardo M: A review and a new hypothesis for non-immunological pathogenetic mechanisms in vitiligo. Pigment Cell Res 2006;19:406-411.
86.
Passeron T, Ortonne JP: Physiopathology and genetics of vitiligo. J Autoimmun 2005;25 (suppl):63-68.
87.
Abdel Fattah NS, Shaheen MA, Ebrahim AA, El Okda ES: Tissue and blood superoxide dismutase activities and malondialdehyde levels in different clinical severities of acne vulgaris. Br J Dermatol 2008;159:1086-1091.
88.
Briganti S, Picardo M: Antioxidant activity, lipid peroxidation and skin diseases. What's new. J Eur Acad Dermatol Venereol 2003;17:663-669.
89.
Kaur S, Zilmer M, Eisen M, Kullisaar T, Rehema A, Vihalemm T: Patients with allergic and irritant contact dermatitis are characterized by striking change of iron and oxidized glutathione status in nonlesional area of the skin. J Invest Dermatol 2001;116:886-890.
90.
Biesalski HK, Berneburg M, Grune T, Kerscher M, Krutmann J, Raab B, Reimann J, Reuther T, Robert L, Schwarz T: Oxidative and premature skin ageing. Exp Dermatol 2003;12(suppl 3):3-15.
91.
Nishigori C, Hattori Y, Arima Y, Miyachi Y: Photoaging and oxidative stress. Exp Dermatol 2003;12:18-21.
92.
Yaar M, Eller MS, Gilchrest BA: Fifty years of skin aging. J Investig Dermatol Symp Proc 2002;7:51-58.
93.
Fisher D, Lichti FU, Lucy JA: Environmental effects on the autoxidation of retinol. Biochem J 1972;130:259-270.
94.
Hekimi S, Guarente L: Genetics and the specificity of the aging process. Science 2003;299:1351-1354.
95.
Harman D: Aging: overview. Ann N Y Acad Sci 2001;928:1-21.
96.
Kohen R, Gati I: Skin low molecular weight antioxidants and their role in aging and in oxidative stress. Toxicology 2000;148:149-157.
97.
Mariéthoz E, Richard MJ, Polla LL, Kreps SE, Dall'Ava J, Polla BS: Oxidant/antioxidant imbalance in skin aging: environmental and adaptive factors. Rev Environ Health 1998; 13:147-168.
98.
Enderlin V, Alfos S, Pallet V, Garcin H, Azais-Braesco V, Jaffard R, Higueret P: Aging decreases the abundance of retinoic acid (RAR) and triiodothyronine (TR) nuclear receptor mRNA in rat brain: effect of the administration of retinoids. FEBS Lett 1997;412:629-632.
99.
Peng YM, Peng YS, Lin Y, Moon T, Roe DJ, Ritenbaugh C: Concentrations and plasma-tissue-diet relationships of carotenoids, retinoids, and tocopherols in humans. Nutr Cancer 1995;23:233-246.
100.
Sorg O, Tran C, Carraux P, Grand D, Hugin A, Didierjean L, Saurat JH: Spectral properties of topical retinoids prevent DNA damage and apoptosis after acute UVB exposure in hairless mice. Photochem Photobiol 2005;81:830-836.
101.
Tran C, Sorg O, Carraux P, Didierjean L, Saurat JH: Topical delivery of retinoids counteracts the UVB-induced epidermal vitamin A depletion in hairless mouse. Photochem Photobiol 2001;73:425-431.
102.
Tran C, Kasraee B, Grand D, Carraux P, Didierjean L, Sorg O, Saurat JH: Pharmacology of RALGA, a mixture of retinaldehyde and glycolic acid. Dermatology 2005;210(suppl 1):6-13.
103.
Ross AC: Retinoid production and catabolism: role of diet in regulating retinol esterification and retinoic acid oxidation. J Nutr 2003;133:291S-296S.
104.
Shimada T, Ross AC, Muccio DD, Brouillette WJ, Shealy YF: Regulation of hepatic lecithin:retinol acyltransferase activity by retinoic acid receptor-selective retinoids. Arch Biochem Biophys 1997;344:220-227.
105.
Wolf G: Retinoic acid homeostasis: retinoic acid regulates liver retinol esterification as well as its own catabolic oxidation in liver. Nutr Rev 2001;59:391-394.
106.
Antille C, Tran C, Sorg O, Saurat JH: Topical beta-carotene is converted to retinyl esters in human skin ex vivo and mouse skin in vivo. Exp Dermatol 2004;13:558-561.
107.
Lindqvist A, Andersson S: Cell type-specific expression of beta-carotene 15,15′-mono-oxygenase in human tissues. J Histochem Cytochem 2004;52:491-499.
108.
Sporn MB, Roberts AB, Goodman DS: The Retinoids. Biology, Chemistry, and Medicine, ed 2. New York, Raven Press, 1994.
109.
Karsten AE, Smit JE: Modeling and verification of melanin concentration on human skin type. Photochem Photobiol 2012;88:469-474.
110.
Antille C, Tran C, Sorg O, Carraux P, Didierjean L, Saurat JH: Vitamin A exerts a photoprotective action in skin by absorbing ultraviolet B radiation. J Invest Dermatol 2003;121:1163-1167.
111.
Bel A, Fort-Lacoste L, Ginestar-Gonzales J, Navarro R: Glycylglycine oleamide in dermo-cosmetology. France, 1999, WO/1999/ 048470 A1.
112.
Kligman AM, Grove GL, Hirose R, Leyden JJ: Topical tretinoin for photoaged skin. J Am Acad Dermatol 1986;15:836-859.
113.
Maddin S, Lauharanta J, Agache P, Burrows L, Zultak M, Bulger L: Isotretinoin improves the appearance of photodamaged skin: results of a 36-week, multicenter, double-blind, placebo-controlled trial. J Am Acad Dermatol 2000;42:56-63.
114.
Griffiths CE: The role of retinoids in the prevention and repair of aged and photoaged skin. Clin Exp Dermatol 2001;26:613-618.
115.
Kang S, Fisher GJ, Voorhees JJ: Photoaging: pathogenesis, prevention, and treatment. Clin Geriatr Med 2001;17:643-659, v-vi.
116.
Griffiths CE, Kang S, Ellis CN, Kim KJ, Finkel LJ, Ortiz-Ferrer LC, White GM, Hamilton TA, Voorhees JJ: Two concentrations of topical tretinoin (retinoic acid) cause similar improvement of photoaging but different degrees of irritation. A double-blind, vehicle-controlled comparison of 0.1 and 0.025% tretinoin creams. Arch Dermatol 1995;131:1037-1044.
117.
Leyden J, Grove G, Zerweck C: Facial tolerability of topical retinoid therapy. J Drugs Dermatol 2004;3:641-651.
118.
Saurat JH, Sorg O: Topical natural retinoids. The ‘proligand-non-ligand' concept. Dermatology 1999;199(suppl 1):1-2.
119.
Creidi P, Vienne MP, Ochonisky S, Lauze C, Turlier V, Lagarde JM, Dupuy P: Profilometric evaluation of photodamage after topical retinaldehyde and retinoic acid treatment. J Am Acad Dermatol 1998;39:960-965.
120.
Saurat JH, Didierjean L, Masgrau E, Piletta PA, Jaconi S, Chatellard-Gruaz D, Gumowski D, Masouyé I, Salomon I, Siegenthaler G: Topical retinaldehyde on human skin: biological effects and tolerance. J Invest Dermatol 1994;103:770-774.
121.
Stefanaki C, Stratigos A, Katsambas A: Topical retinoids in the treatment of photoaging. J Cosm Dermatol 2005;4:130-134.
122.
Stratigos AJ, Katsambas AD: The role of topical retinoids in the treatment of photoaging. Drugs 2005;65:1061-1072.
123.
Gervin CM, McCulla A, Williams M, Ouhtit A: Dysfunction of p53 in photocarcinogenesis. Front Biosci 2003;8:s715-s717.
124.
Benjamin CL, Ananthaswamy HN: p53 and the pathogenesis of skin cancer. Toxicol Appl Pharmacol 2007;224:241-248.
125.
Hsu TC, Young MR, Cmarik J, Colburn NH: Activator protein 1 (AP-1)- and nuclear factor kappaB (NF-kappaB)-dependent transcriptional events in carcinogenesis. Free Radic Biol Med 2000;28:1338-1348.
126.
Rittie L, Fisher GJ: UV-light-induced signal cascades and skin aging. Ageing Res Rev 2002;1:705-720.
127.
Mrass P, Rendl M, Mildner M, Gruber F, Lengauer B, Ballaun C, Eckhart L, Tschachler E: Retinoic acid increases the expression of p53 and proapoptotic caspases and sensitizes keratinocytes to apoptosis: a possible explanation for tumor preventive action of retinoids. Cancer Res 2004;64:6542-6548.
128.
Darwiche N, Bazzi H, El-Touni L, Abou-Lteif G, Doueiri R, Hatoum A, Maalouf S, Gali-Muhtasib H: Regulation of ultraviolet B radiation-mediated activation of AP1 signaling by retinoids in primary keratinocytes. Radiat Res 2005;163:296-306.
129.
Fanjul A, Dawson MI, Hobbs PD, Jong L, Cameron JF, Harlev E, Graupner G, Lu XP, Pfahl M: A new class of retinoids with selective inhibition of AP-1 inhibits proliferation. Nature 1994;372:107-111.
130.
Bayon Y, Ortiz MA, Lopez-Hernandez FJ, Gao F, Karin M, Pfahl M, Piedrafita FJ: Inhibition of IkappaB kinase by a new class of retinoid-related anticancer agents that induce apoptosis. Mol Cell Biol 2003;23:1061-1074.
131.
Na SY, Kang BY, Chung SW, Han SJ, Ma X, Trinchieri G, Im SY, Lee JW, Kim TS: Retinoids inhibit interleukin-12 production in macrophages through physical associations of retinoid X receptor and NFkappaB. J Biol Chem 1999;274:7674-7680.
132.
Ralhan R, Kaur J: Retinoids as chemopreventive agents. J Biol Regul Homeost Agents 2003;17:66-91.
133.
So PL, Lee K, Hebert J, Walker P, Lu Y, Hwang J, Kopelovich L, Athar M, Bickers D, Aszterbaum M, Epstein EH Jr: Topical tazarotene chemoprevention reduces basal cell carcinoma number and size in Ptch1+/- mice exposed to ultraviolet or ionizing radiation. Cancer Res 2004;64:4385-4389.
134.
Zusi FC, Lorenzi MV, Vivat-Hannah V: Selective retinoids and rexinoids in cancer therapy and chemoprevention. Drug Discov Today 2002;7:1165-1174.
135.
Halliday GM, Robertson BO, Barnetson RS: Topical retinoic acid enhances, and a dark tan protects, from subedemal solar-simulated photocarcinogenesis. J Invest Dermatol 2000;114:923-927.
136.
Junqueira VB, Barros SB, Chan SS, Rodrigues L, Giavarotti L, Abud RL, Deucher GP: Aging and oxidative stress. Mol Aspects Med 2004;25:5-16.
137.
Yamamoto Y: Role of active oxygen species and antioxidants in photoaging. J Dermatol Sci 2001;27(suppl 1):S1-S4.
138.
Shklar G: Mechanisms of cancer inhibition by anti-oxidant nutrients. Oral Oncol 1998;34:24-29.
139.
Afaq F, Mukhtar H: Botanical antioxidants in the prevention of photocarcinogenesis and photoaging. Exp Dermatol 2006;15:678-684.
140.
Mavon A, Raufast V, Redoules D: Skin absorption and metabolism of a new vitamin E prodrug, delta-tocopherol-glucoside: in vitro evaluation in human skin models. J Control Release 2004;100:221-231.
141.
Boisnic S, Branchet-Gumila MC, Nocera T: Comparative study of the anti-aging effect of retinaldehyde alone or associated with pretocopheryl in a surviving human skin model submitted to ultraviolet A and B irradiation. Int J Tissue React 2005;27:91-99.
142.
Sorg O, Tran C, Saurat JH: Cutaneous vitamins A and E in the context of ultraviolet- or chemically-induced oxidative stress. Skin Pharmacol Appl Skin Physiol 2001;14:363-372.
143.
Kaur IP, Kapila M, Agrawal R: Role of novel delivery systems in developing topical antioxidants as therapeutics to combat photoageing. Ageing Res Rev 2007;6:271-288.
144.
Black HS: Pro-oxidant and anti-oxidant mechanism(s) of BHT and beta-carotene in photocarcinogenesis. Front Biosci 2002;7:d1044-d1055.
145.
Halliwell B: Are polyphenols antioxidants or pro-oxidants? What do we learn from cell culture and in vivo studies? Arch Biochem Biophys 2008;476:107-112.
146.
Minetti M, Agati L, Malorni W: The microenvironment can shift erythrocytes from a friendly to a harmful behavior: pathogenetic implications for vascular diseases. Cardiovasc Res 2007;75:21-28.
147.
Omaye ST, Krinsky NI, Kagan VE, Mayne ST, Liebler DC, Bidlack WR: beta-carotene: friend or foe? Fundam Appl Toxicol 1997;40:163-174.
148.
Nohynek GJ, Meuling WJ, Vaes WH, Lawrence RS, Shapiro S, Schulte S, Steiling W, Bausch J, Gerber E, Sasa H, Nau H: Repeated topical treatment, in contrast to single oral doses, with vitamin A-containing preparations does not affect plasma concentrations of retinol, retinyl esters or retinoic acids in female subjects of child-bearing age. Toxicol Lett 2006;163:65-76.
149.
Sorg O, Kuenzli S, Saurat JH: Side effects and pitfalls in retinoid therapy; in Vahlquist A, Duvic M (eds): Retinoids and Carotenoids in Dermatology. New York, Informa Healthcare, 2007, pp 225-248.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.